Xortx TherapeuticsXRTX
13F holders, Q1 2024 (March 31)4holders
$3.96avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Xortx Therapeutics Inc. (XRTX) in their 13F filings. The largest holders were Bank of Montreal ($60K), Osaic Holdings, Inc. ($4K) and JPMorgan Chase & Co. ($1K).
- Company
- Xortx Therapeutics Inc.
- CUSIP
- 98420Q306
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $61K |
| Exits | 2 | $160.6M |
Ownership 4 holders
| Bank of Montreal | 0.00% | New | 14,994 | $60K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,153 | $4K |
| JPMorgan Chase & Co. | 0.00% | New | 254 | $1K |
| Clearstead Advisors, LLC | 0.00% | No change | 277 | $696 |
"% of holder's portfolio" is XRTX's weight in each manager's 13F, not the share of Xortx Therapeutics Inc. the manager owns.